Companies · Other Health Care

Navierre Holdings, LLC

MONTVALE · Other Health Care

Diligence memoA one-page analyst read on Navierre Holdings, LLC — recommendation, valuation, rhythm, risks.
$1.1M
Total raised · real
2
Rounds
0.1×
Latest step-up
Top 65%
Sector rank · raised
Seed
Latest stage · inferred · Mon Nov 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Navierre Holdings, LLC looks under-valued against its niche peers and is at-risk on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.08× the median modeled value of Seed Other Health Care companies in 2022–2024 (244 peers) — value vs value, same stage and era.
At-risk
  • Last raise 3.6 yr ago; this sector typically re-raises about every 14 months.
  • Past due for a raise versus sector cadence — watch for distress or a bridge.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Issuer-vehicle patternmedium confidence

Navierre Holdings, LLC behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
4.4 yr record
Peak capital year was 2022 with $1.1M across 2 filings.
Market position
ahead of 36% of Other Health Care peers
Capital scale is ahead of 36% of Other Health Care peers; modeled value is above 6% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Consistent
Canonical totals and visible filing detail are broadly aligned.
What triggered this
  • Legal name looks like an issuer vehicle rather than a product company.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2022: $1.1M across 2 filings.
  • Largest single filing was $1.0M on 2022-02-09.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Navierre Holdings, LLC is one of 5377 Other Health Care companies tracked from MONTVALE. By capital raised it ranks in the long tail (ahead of 36% of sector peers), and in the long tail by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
3
Investors (latest)
2021
Year incorporated
2022-11-28
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$5.0M$10M$15M$20MSeed · 2022-02-09 Raised $1.0M (real) Modeled valuation $13M (est)$1.0M$13MSeed2022Seed · 2022-11-28 Raised $105K (real) Modeled valuation $924K (est)$105K$924KSeed2022+$105KCumulative $1.1M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Seed$1.0M · 2022
Seed extension$105K · 2022

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 50%.

Modeled valuation trajectory
$924K
Base estimate est.
$89K
Conservative case
$3.8M
Upside case
$525K
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Seeda $1.0M–$4.0M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Seed · modeled $12.6M · 2022-02-092022Seed · modeled $924K · 2022-11-282022
Model inputs · modeled:benchmark-stage-stepup-v1
20%
Dilution assumption
Implied ownership sold in the financing.
38%
Survival probability
17% low · 58% high
1.54×/yr
Annual markup
2.01×/yr upside case
3.6 yr
Elapsed time used
3.6 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
10 mo
Avg between rounds
$1.4M/yr
Capital velocity
4.4 yr
On record since
2022
First round
2
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 0.5× of median
This company$1.1M
Sector median$2.4M
Latest round — vs other Seed rounds in sector (real $, this stage) 0.1× of median
This company$105K
Sector median$1.7M
Modeled value — vs sector median (estimate, all stages) 0.0× of median
This company$924K
Sector median$22.1M

Raised more than 36% of sector peers (real $). Modeled value above 6% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #240 of 244.

This companyCohort peer
$100K$1.0M$10.0M$100.0M$100K$1.0M$10.0MCapital raised (log)Elmntri LLC · Seed Raised $4.0M · modeled $46.1M (est)Atreo, Inc. · Seed Raised $3.8M · modeled $42.1M (est)descendantsDNA, Inc. · Seed Raised $3.4M · modeled $40.8M (est)Westover Project Investor LLC · Seed Raised $4.0M · modeled $40.0M (est)Dentulu Inc · Seed Raised $6.4M · modeled $37.7M (est)Emmacare.com LLC · Seed Raised $3.0M · modeled $37.2M (est)IR-Med, Inc. · Seed Raised $5.4M · modeled $37.0M (est)SDH Parent 2 LLC · Seed Raised $3.0M · modeled $36.7M (est)TecTraum, Inc. · Seed Raised $7.8M · modeled $36.7M (est)DBN BCS II Investments, LLC · Seed Raised $3.0M · modeled $34.0M (est)USRC Baldwin Hills, LLC · Seed Raised $2.8M · modeled $34.0M (est)Flex Operating Room, Inc. · Seed Raised $6.2M · modeled $31.9M (est)Navierre Holdings, LLC (this company) Raised $1.1M · modeled $924K (est)Navierre Holdings, LLC
CompanyStageRaised · realValue · estvs peer med.
Elmntri LLCSeed$4.0M$46.1M3.83×
Atreo, Inc.Seed$3.8M$42.1M3.50×
descendantsDNA, Inc.Seed$3.4M$40.8M3.40×
Westover Project Investor LLCSeed$4.0M$40.0M3.33×
Dentulu IncSeed$6.4M$37.7M3.13×
Emmacare.com LLCSeed$3.0M$37.2M3.10×
IR-Med, Inc.Seed$5.4M$37.0M3.08×
SDH Parent 2 LLCSeed$3.0M$36.7M3.05×
TecTraum, Inc.Seed$7.8M$36.7M3.05×
DBN BCS II Investments, LLCSeed$3.0M$34.0M2.83×
USRC Baldwin Hills, LLCSeed$2.8M$34.0M2.82×
Flex Operating Room, Inc.Seed$6.2M$31.9M2.65×
Navierre Holdings, LLC this companySeed$1.1M$924K0.08×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Seed$1.0M2022-02-09$5.1M$12.6M90%
Seed$105K2022-11-28$525K$924K90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Seed$1.0M2022-02-09
    • First recorded raise — entered as Seed.
    • 36 investors on this round.
  2. Seed$105K2022-11-28
    • Raised 10 mo later, in step with the ~14 mo sector norm.
    • Round 9.7× smaller than the prior — bridge or down round.
    • 3 investors on this round.
Intelligence
2023 ~Q3
Modeled next raise · ~10mo cadence
$105K
Modeled next size est.range $105K$168K
0.1×
Last step-up
$1.4M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Gaurav B. Singhvi2022-11
Jeff B. Stelnik2022-11
Mustafa B. Dinani2022-02
Registry & provenance

Navierre Holdings, LLC is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1909320
SEC CIK
2021
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Renerva LLCOther Health CareSeed$1.3M$859Ksame sector · same stage
Emerald Coast Surgery Center L POther Health CareSeed$1.4M$1.0Msame sector · same stage
Golden Triangle SurgiCenter, L.P.Other Health CareSeed$1.5M$892Ksame sector · same stage
Amity Holdings, LLCOther Health CareSeed$1.9M$1.2Msame sector · same stage
Surgicare Of Jackson, Ltd.Other Health CareSeed$2.1M$786Ksame sector · same stage
Rose Management Group Inc.Other Health CareSeed$2.1M$1.2Msame sector · same stage
Ten Mile Surgery Center, LLCOther Health CareSeed$2.1M$1.1Msame sector · same stage
Structural Elements Franchising, LLCOther Health CareSeed$2.3M$1.5Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Navvis & Company, LLCOther Health CareSeries C$1.3B89%
Nava Management, LLCOther Health CareSeed$46.0M87%
NM-ASWC Holdings, LLCOther Health CareSeries B$255.6M84%
Naavacare LLCOther Health CarePre-Seed$2.7M84%
BNVC Group Holdings, Inc.Other Health CareSeries D+$6.9B84%
Nocira, LlcOther Health CareSeed$96.7M84%
Amity Holdings, LLCOther Health CareSeed$1.2M83%
Navier, Inc.OtherSeed$20.0M83%
Frequently asked
How much funding has Navierre Holdings, LLC raised?
Navierre Holdings, LLC has raised approximately $1.1M in disclosed capital across 2 recorded financing rounds, aggregated from public filings.
What is Navierre Holdings, LLC's estimated valuation?
Provath's modeled valuation for Navierre Holdings, LLC is approximately $924K (modeled range $89K–$3.8M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Navierre Holdings, LLC at?
Navierre Holdings, LLC's latest modeled financing stage is Seed. Its most recent recorded round closed around Mon Nov 28.
What does Navierre Holdings, LLC do and where is it based?
Navierre Holdings, LLC operates in the Other Health Care sector, based in MONTVALE.
Explore related

See where Navierre Holdings, LLC sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Navierre Holdings, LLC, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.